Zai Lab Limited disclosed on 28 October 2026 that it has issued 113.40 million new ordinary shares as the underlying securities for American Depositary Shares (ADSs) sold to investors under a Securities Purchase Agreement relating to a private placement.

The new shares, priced at HK$17.28 per share (equivalent to US$22.04 per ADS, with each ADS representing ten ordinary shares), expand the company’s issued share base to 1.25 billion from 1.14 billion, marking a 9.97% increase. No treasury shares were involved, and the company confirmed full compliance with Hong Kong Stock Exchange listing rules and all regulatory requirements.

Following the transaction, Zai Lab’s issued share capital stands at 1,251.23 million ordinary shares. No share repurchases, redemptions, or treasury-share sales were reported for the period.